HN2003000050A - Composiciones farmaceuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporida. - Google Patents
Composiciones farmaceuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporida.Info
- Publication number
- HN2003000050A HN2003000050A HN2003000050A HN2003000050A HN2003000050A HN 2003000050 A HN2003000050 A HN 2003000050A HN 2003000050 A HN2003000050 A HN 2003000050A HN 2003000050 A HN2003000050 A HN 2003000050A HN 2003000050 A HN2003000050 A HN 2003000050A
- Authority
- HN
- Honduras
- Prior art keywords
- zoniporida
- mesilate
- solubility
- procedures
- improve
- Prior art date
Links
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 title abstract 2
- 229950002475 mesilate Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 abstract 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N anhydrous guanidine Natural products NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A FORMULACIONESLIOFILIZADAS QUE CONTIENEN LA SAL MESILATO DEL COMPUESTO DE LA FORMULA I, N-(5-CICLOPROPIL-1-QUINOLIN-5-IL-1H-PIRAZOL-4-CARBONIL)- GUANIDINA, (DE AQUI EN ADELANTE "ZONIPORIDA").
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35302502P | 2002-01-30 | 2002-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HN2003000050A true HN2003000050A (es) | 2003-08-22 |
Family
ID=27663165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HN2003000050A HN2003000050A (es) | 2002-01-30 | 2003-01-28 | Composiciones farmaceuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporida. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20030149075A1 (es) |
| EP (1) | EP1472242A1 (es) |
| JP (1) | JP2005521670A (es) |
| AR (1) | AR038322A1 (es) |
| BR (1) | BR0307195A (es) |
| CA (1) | CA2472342A1 (es) |
| DO (1) | DOP2003000569A (es) |
| GT (1) | GT200300012A (es) |
| HN (1) | HN2003000050A (es) |
| MX (1) | MXPA04006615A (es) |
| PA (1) | PA8564501A1 (es) |
| PE (1) | PE20030817A1 (es) |
| SV (1) | SV2004001470A (es) |
| TW (1) | TW200302721A (es) |
| UY (1) | UY27624A1 (es) |
| WO (1) | WO2003064409A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3672571T (lt) | 2017-08-25 | 2021-12-10 | Pfizer Inc. | Farmacinė vandeninė vaisto forma, apimanti 1-(4-{[4-(dimetilamino)piperidin-1-il]karbonil}fenil)-3-[4-(4,6-dimorfolin-4-il-1,3,5-triazin-2-il)fenil]karbamidą |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU739403B2 (en) * | 1998-02-27 | 2001-10-11 | Pfizer Products Inc. | N-((substituted five-membered di- or triaza diunsaturated ring)carbonyl) guanidine derivatives for the treatment of ischemia |
| UA72002C2 (en) * | 1999-10-29 | 2005-01-17 | Pfizer Prod Inc | Inhibitors crystals of sodium-hydrogen exchange of 1 type, a method for the preparation thereof (variants), a pharmaceuticalcomposition based thereon and a method for the reduction of tissue damage |
-
2003
- 2003-01-20 CA CA002472342A patent/CA2472342A1/en not_active Abandoned
- 2003-01-20 EP EP03700406A patent/EP1472242A1/en not_active Withdrawn
- 2003-01-20 MX MXPA04006615A patent/MXPA04006615A/es not_active Application Discontinuation
- 2003-01-20 BR BR0307195-2A patent/BR0307195A/pt not_active Application Discontinuation
- 2003-01-20 JP JP2003564032A patent/JP2005521670A/ja active Pending
- 2003-01-20 WO PCT/IB2003/000146 patent/WO2003064409A1/en not_active Ceased
- 2003-01-23 GT GT200300012A patent/GT200300012A/es unknown
- 2003-01-27 UY UY27624A patent/UY27624A1/es not_active Application Discontinuation
- 2003-01-28 HN HN2003000050A patent/HN2003000050A/es unknown
- 2003-01-28 PE PE2003000085A patent/PE20030817A1/es not_active Application Discontinuation
- 2003-01-28 AR ARP030100239A patent/AR038322A1/es unknown
- 2003-01-28 DO DO2003000569A patent/DOP2003000569A/es unknown
- 2003-01-29 TW TW092102042A patent/TW200302721A/zh unknown
- 2003-01-29 SV SV2003001470A patent/SV2004001470A/es not_active Application Discontinuation
- 2003-01-30 US US10/354,288 patent/US20030149075A1/en not_active Abandoned
- 2003-01-30 PA PA20038564501A patent/PA8564501A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003064409A1 (en) | 2003-08-07 |
| UY27624A1 (es) | 2003-08-29 |
| EP1472242A1 (en) | 2004-11-03 |
| PE20030817A1 (es) | 2003-10-04 |
| DOP2003000569A (es) | 2003-08-15 |
| BR0307195A (pt) | 2004-11-03 |
| SV2004001470A (es) | 2004-05-07 |
| US20030149075A1 (en) | 2003-08-07 |
| AR038322A1 (es) | 2005-01-12 |
| PA8564501A1 (es) | 2003-09-17 |
| GT200300012A (es) | 2003-08-28 |
| MXPA04006615A (es) | 2004-10-04 |
| CA2472342A1 (en) | 2003-08-07 |
| TW200302721A (en) | 2003-08-16 |
| JP2005521670A (ja) | 2005-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12022553603A1 (en) | Triazine derivative having virus propagation inhibitory effect, and pharmaceutical composition containing same | |
| PA8591701A1 (es) | Derivados de pirrolopirimidina | |
| EE05103B1 (et) | Famatseutilised kompositsioonid, mis sisaldavad asetidiini derivaate, asetidiini derivaadid ja nende valmistamise meetodid | |
| BRPI0511504A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, e, agente preventivo ou terapêutico para uma doença resultante de beta-amilóides | |
| BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
| CO5590918A2 (es) | Formulaciones | |
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| HN2001000244A (es) | Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas. | |
| DK1506203T3 (da) | Syntese af epothiloner, mellemprodukter deraf, analoger deraf og anvendelser deraf | |
| ES2421948T3 (es) | Compuestos y composiciones para suministrar agentes activos | |
| UY30274A1 (es) | Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones | |
| EA200401114A3 (ru) | Замещённые гидроксиэтиламины | |
| BR0307071A (pt) | ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico | |
| PA8573501A1 (es) | Derivados de benzoxazina y su empleo | |
| PT1251846E (pt) | Taxanos com carbonato c-4 | |
| BR0314352A (pt) | Indóis 2,7-substituìdos e seu uso como moduladores de 5-ht6 | |
| MXPA05011176A (es) | Derivados de carboxamida como agentes antidiabeticos. | |
| BRPI0417858A (pt) | composto, composição farmacêutica, e, uso de uma composição farmacêutica | |
| UY27979A1 (es) | Indoles sustituidos en posición 2,4 | |
| BRPI0406824A (pt) | Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm | |
| BRPI0317188A8 (pt) | novo derivado de 2,4-diamino-1,3,5-triazina | |
| CY1112057T1 (el) | Θεραπευτικος παραγων για διαταραχη επαρκειας τροφης στο στομαχι | |
| DE60005517D1 (de) | Kaliumkanal-blockierende mittel | |
| HN2003000050A (es) | Composiciones farmaceuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporida. | |
| HN2002000354A (es) | Sales de acido citrico de un compuesto terapeutico y composiciones farmaceuticas que la contienen |